EGF and fatty liver disease: Besides, brown adipocyte-derived Neuregulin 4 (Nrg4), a member of the epidermal growth factor (EGF) family of ligands, attenuates hepatic lipogenic signaling and protects mice against diet-induced insulin resistance and hepatic steatosis (142).